A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
Status:
NOT_YET_RECRUITING
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
This is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TCP-25 gel in patients with confirmed DEB or JEB. The study will implement intrasubject randomization, ie, pairs of matching index wounds will be randomly assigned to be treated with a local application of either TCP 25 gel or vehicle gel.